Article info

Extended report
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Authors

  1. Correspondence to Maxime Dougados, Department of Rheumatology, Paris-Descartes University, Assistance Publique Hôpitaux de Paris, Cochin Hospital, 27 rue du Faubourg Saint-Jacques, Paris 75014, France; maxime.dougados{at}cch.aphp.fr
View Full Text

Citation

Dougados M, van der Heijde D, Chen Y, et al
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

Publication history

  • Received June 21, 2016
  • Revised September 6, 2016
  • Accepted September 8, 2016
  • First published September 29, 2016.
Online issue publication 
December 09, 2016
  • Lay summary

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.